These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16916914)

  • 1. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk.
    Jayachandran M; Brunn GJ; Karnicki K; Miller RS; Owen WG; Miller VM
    J Appl Physiol (1985); 2007 Jan; 102(1):429-33. PubMed ID: 16916914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toll-like receptor 4 expression mediates the activation of platelets induced by LPS].
    Ma LP; Wei J; Chang JX; Zhang C; Pei ZX; Yang QH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1564-8. PubMed ID: 20030948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte- and platelet-derived microvesicle interactions following in vitro and in vivo activation of toll-like receptor 4 by lipopolysaccharide.
    Xiong J; Miller VM; Hunter LW; Li Y; Jayachandran M
    PLoS One; 2011; 6(9):e25504. PubMed ID: 21966536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway.
    Zhang G; Han J; Welch EJ; Ye RD; Voyno-Yasenetskaya TA; Malik AB; Du X; Li Z
    J Immunol; 2009 Jun; 182(12):7997-8004. PubMed ID: 19494325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine platelets inhibit E. coli growth and can be activated by bacterial lipopolysaccharide and lipoteichoic acid although superoxide anion production does not occur and platelet activation is not associated with enhanced production by neutrophils.
    Aktan I; Dunkel B; Cunningham FM
    Vet Immunol Immunopathol; 2013 Apr; 152(3-4):209-17. PubMed ID: 23332730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation.
    Zhou H; Andonegui G; Wong CH; Kubes P
    J Immunol; 2009 Oct; 183(8):5244-50. PubMed ID: 19786543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation.
    Qin L; Li G; Qian X; Liu Y; Wu X; Liu B; Hong JS; Block ML
    Glia; 2005 Oct; 52(1):78-84. PubMed ID: 15920727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of resveratrol on the platelet secretory process induced by endotoxin and thrombin.
    Olas B; Wachowicz B; Szewczuk J; Saluk-Juszczak J; Kaca W
    Microbios; 2001; 105(410):7-13. PubMed ID: 11368092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide.
    Arranz A; Androulidaki A; Zacharioudaki V; Martinez C; Margioris AN; Gomariz RP; Tsatsanis C
    Mol Immunol; 2008 May; 45(10):2970-80. PubMed ID: 18336909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor.
    Ward JR; Bingle L; Judge HM; Brown SB; Storey RF; Whyte MK; Dower SK; Buttle DJ; Sabroe I
    Thromb Haemost; 2005 Oct; 94(4):831-8. PubMed ID: 16270639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Suppressive effect of exogenous carbon monoxide on abnormal platelet exocytosis and its molecular mechanism in sepsis].
    Liu D; Xu X; Zhuang M; Song M; Qin W; Wang X; Sun B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Feb; 28(2):110-6. PubMed ID: 26911941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-alpha signaling.
    Chen LW; Chang WJ; Chen PH; Liu WC; Hsu CM
    Shock; 2008 Nov; 30(5):563-70. PubMed ID: 18317407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular TLR4/MD-2 in macrophages senses Gram-negative bacteria and induces a unique set of LPS-dependent genes.
    Shibata T; Motoi Y; Tanimura N; Yamakawa N; Akashi-Takamura S; Miyake K
    Int Immunol; 2011 Aug; 23(8):503-10. PubMed ID: 21712422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine platelets express functional Toll-like receptor-4: lipopolysaccharide-triggered platelet activation is dependent on adenosine diphosphate and thromboxane A2 in dogs.
    Li RHL; Nguyen N; Tablin F
    BMC Vet Res; 2019 Jul; 15(1):245. PubMed ID: 31307465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation and microparticle production through toll-like receptor 4 activation in platelets from recently menopausal women.
    Hashimoto K; Jayachandran M; Owen WG; Miller VM
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):57-62. PubMed ID: 19528814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide-induced toll-like receptor 4 signaling enhances the migratory ability of human esophageal cancer cells in a selectin-dependent manner.
    Rousseau MC; Hsu RY; Spicer JD; McDonald B; Chan CH; Perera RM; Giannias B; Chow SC; Rousseau S; Law S; Ferri LE
    Surgery; 2013 Jul; 154(1):69-77. PubMed ID: 23809486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPS enhances platelets aggregation via TLR4, which is related to mitochondria damage caused by intracellular ROS, but not extracellular ROS.
    Feng G; Yang X; Li Y; Wang X; Tan S; Chen F
    Cell Immunol; 2018 Jun; 328():86-92. PubMed ID: 29653689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
    Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood.
    Montrucchio G; Bosco O; Del Sorbo L; Fascio Pecetto P; Lupia E; Goffi A; Omedè P; Emanuelli G; Camussi G
    Thromb Haemost; 2003 Nov; 90(5):872-81. PubMed ID: 14597983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paying the circadian toll: the circadian response to LPS injection is dependent on the Toll-like receptor 4.
    Paladino N; Leone MJ; Plano SA; Golombek DA
    J Neuroimmunol; 2010 Aug; 225(1-2):62-7. PubMed ID: 20554031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.